Zurich Cantonal Bank’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$331K Sell
35,328
-1,467
-4% -$13.8K ﹤0.01% 1898
2025
Q1
$262K Buy
36,795
+4,540
+14% +$32.3K ﹤0.01% 1963
2024
Q4
$376K Buy
32,255
+5,350
+20% +$62.4K ﹤0.01% 1799
2024
Q3
$553K Sell
26,905
-682
-2% -$14K ﹤0.01% 1502
2024
Q2
$617K Buy
27,587
+4,824
+21% +$108K ﹤0.01% 1344
2024
Q1
$626K Sell
22,763
-622
-3% -$17.1K ﹤0.01% 1327
2023
Q4
$713K Buy
23,385
+647
+3% +$19.7K ﹤0.01% 1261
2023
Q3
$719K Buy
22,738
+2,656
+13% +$84K ﹤0.01% 1174
2023
Q2
$819K Buy
20,082
+1,933
+11% +$78.8K ﹤0.01% 1045
2023
Q1
$676K Buy
18,149
+1,329
+8% +$49.5K ﹤0.01% 1112
2022
Q4
$587K Buy
16,820
+1,043
+7% +$36.4K ﹤0.01% 1160
2022
Q3
$883K Buy
15,777
+247
+2% +$13.8K 0.01% 886
2022
Q2
$804K Sell
15,530
-723
-4% -$37.4K ﹤0.01% 952
2022
Q1
$1.18M Buy
16,253
+174
+1% +$12.6K 0.01% 870
2021
Q4
$1.9M Buy
16,079
+2,424
+18% +$287K 0.01% 760
2021
Q3
$1.83M Buy
13,655
+832
+6% +$112K 0.01% 772
2021
Q2
$2.08M Buy
12,823
+1,283
+11% +$208K 0.01% 719
2021
Q1
$926K Buy
11,540
+5,337
+86% +$428K 0.01% 908
2020
Q4
$337K Buy
6,203
+778
+14% +$42.3K ﹤0.01% 1508
2020
Q3
$108K Hold
5,425
﹤0.01% 1948
2020
Q2
$114K Buy
5,425
+2,299
+74% +$48.3K ﹤0.01% 1873
2020
Q1
$38K Buy
3,126
+1,430
+84% +$17.4K ﹤0.01% 2069
2019
Q4
$25K Hold
1,696
﹤0.01% 2448
2019
Q3
$23K Buy
1,696
+439
+35% +$5.95K ﹤0.01% 2411
2019
Q2
$21K Hold
1,257
﹤0.01% 2454
2019
Q1
$21K Sell
1,257
-4,476
-78% -$74.8K ﹤0.01% 2401
2018
Q4
$78K Hold
5,733
﹤0.01% 1752
2018
Q3
$164K Hold
5,733
﹤0.01% 1426
2018
Q2
$157K Buy
5,733
+4,807
+519% +$132K ﹤0.01% 1385
2018
Q1
$20K Hold
926
﹤0.01% 2416
2017
Q4
$18K Buy
+926
New +$18K ﹤0.01% 2430